Biotech

Latest Articles

Former Seagen chief executive officer reveals brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2013 for an enormous $4...

Ironwood produces further bid for $1B GI drug along with brand-new subgroup records

.On the heels of a period 3 win that failed to blow away real estate investors, Ironwood Pharmaceuti...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Don't quit Monte Rosa Therapeutics right now. The Boston-based biotech is enjoying after signing a ...

Jade takes exec staff with Chinook vets-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of considerable management hirings, shooting...

Septerna goes public along with upsized offering of $288M

.Commemorating his business's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer call...

AbbVie creates Richter wealthier, paying for $25M to create finding pact

.AbbVie has returned to the resource of its antipsychotic powerhouse Vraylar seeking another smash h...

GenSight enters final full weeks of money path as earnings flow squeezes by of grasp

.GenSight Biologics is full weeks out of losing loan. Once more. The biotech just possesses enough m...

AZ licenses disposed of unusual health condition medicine to Monopar Therapeutics

.Monopar Therapies is actually recovering a medication from the scrap heap of AstraZeneca's rare ail...

Arcus' new HIF-2a records in renal cancer cells mention possible edge over Merck's Welireg, experts say

.With brand-new data out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of experts e...

Roche bets up to $1B to grow Dyno gene therapy distribution contract

.After forming a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is actually back f...

Lundbeck slashes market value of $250M Abide purchase after discomfort problem

.Lundbeck is slashing the book value of its $250 thousand Abide Therapies buyout in reaction to phas...

Real- Globe Information Satisfies Clinical Test Style: Improving Process as well as Internet Site Variety

.The integration of real-world data (RWD) into protocol feasibility and also website assortment has ...

Where are they today? Catching up with previous Brutal 15 honorees

.At this year's Fierce Biotech Summit in Boston ma, our team caught up with leaders in the biotech f...

Merck gets preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually putting down $30 million ahead of time to buy Yale spinout Modifi Biosci...

Radiopharma Alpha-9 raises $175M set C to finance scientific push

.Alpha-9 Oncology has increased a $175 thousand set C cycle to money its own clinical-stage radiopha...

Ocuphire to transform right into genetics therapy biotech via Piece acquistion

.Eye medicine creator Ocuphire Pharma is acquiring gene therapy creator Opus Genetics in an all-stoc...

Roche culls cough candidate, turns KRAS course in Q3 update

.Roche's severe coughing course has faltered to a halt. The drugmaker, which axed the plan after the...

Merck- Gilead long-acting oral combo decreases HIV for 48 weeks

.Gilead Sciences as well as Merck &amp Co. have guided their once-weekly HIV mix treatment past yet ...

Lykos accepts FDA view that MDMA permission relies on new test

.Lykos Therapies might possess lost three-quarters of its own staff following the FDA's denial of it...

Septerna intends $158M IPO to money readouts for GPCR pipe

.Septerna might be actually yet to make known "any sort of meaningful scientific records," however t...